Atlas Trials

Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT04526080 · WITHDRAWN

Trial details

NCT number
NCT04526080
Sponsor
Wake Forest University Health Sciences
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2021-04-01
Primary completion
2022-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.